Science and innovation are the lifeblood of our company. But we’re doing more than developing medicines that perform well in the lab—we’re elevating the current standard of care to bring greater benefits to our patients.
Our Science Impacts Lives
$3 million
invested by AbbVie in New Zealand medical research and clinical trials in 2017
Therapeutic Focus Areas
Researching Areas of Unmet Medical Need
We’re constantly finding new ways to address patients’ most serious health issues. We concentrate our efforts on a core set of therapeutic areas—ones where we’ve proven our expertise, and where we feel we can have an even greater impact on disease and how it is managed.
Where We Research
Eight State-of-the-Art R&D Centers:
Lake County, Illinois, US
Redwood
City, California, US
Sunnyvale, California, US
(Pharmacyclics)
South San Francisco, California, US
Cambridge, Massachusetts, US
Worcester, Massachusetts, US
Ludwigshafen, Germany
Tokyo, Japan
Our Products
A Portfolio of Medicines
We aim to develop innovative therapies for health conditions where there is a significant need. Our medicines are approved by Medsafe for use in New Zealand.
Pipeline
Devoted to New Discoveries
Our scientists are advancing a pipeline of specialty medicines with a
focus on cancer, immune-mediated conditions, neurodegenerative
diseases and more.
Clinical Trials
Advancing Medical Knowledge
We have investigational compounds in development within each of our therapeutic areas. A critical component of medicinal product development is clinical research, which involves conducting clinical trials to evaluate the safety and efficacy of new therapies.
Clinical Trials and Me
Make New Medicines Possible
Whether you or a relative are interested in participating in a trial, our Clinical Trials and Me website can help address your questions. It offers information about clinical trials and lists our current clinical trials. You’ll also learn how to prepare for one and what to expect during and after a clinical trial.